At Micro Labs, we are dedicated to developing top of the line pharmaceutical products adhering to high quality specifications by a world class research team. The continuous strive for perfection has led us to push our standards of manufacturing by building state-of-the-art facilities. These state-of-the-art manufacturing facilities and infrastructure facilitated the development of Micro’s Organic Growth in the regulated markets. Our vision to create a Vertical Integrated Company offering products with a competitive advantage in Global markets has led to the set up of its very own API Unit.
The API Unit is a backbone on which rests the manufacturing of quality APIs cost efficiently, thus enabling us to be a globally competitive pharmaceutical company. We produce APIs involving complex chemistries and innovative non-infringing process.
Built over an area of 24000 square meters, the API Unit of Micro Labs is a star addition to the company’s glittering profile. The unit boasts of all the modern facilities for research and production teams. We aim to increase our presence over global markets with the API.
This unit will facilitate the robust production of APIs in therapeutic areas such as anti-hypertensive, diuretic, anti- malarial, anti-inflammatory, and ophthalmology. A full-fledged pilot plant supports the scale-up activity of all new developments. The commercial and pilot blocks have an advanced finishing area that meets modern day production standards.
GMP-compliant requirements have been strictly followed in the construction of the API manufacturing unit. A total strength of 94 employees ply their trade at the unit including a technical staff of 85 employees that comprises of engineers, science graduates, recipients of prestigious Doctorates, and diploma holders.
For Micro Labs, the API is a strategic addition in our foray towards a global arena. An impressive R&D centre and Kilo Lab facility is one of the key features of the unit, which enables to develop high value and low volume APIs. The modern facilities are a perfect complement to the talent of our product development team. The research team can express their true potential, which in turn helps Micro Labs to cater its products for the global market.
The R&D division and Kilo Lab facility of the API manufacturing unit devotes all its energies and is constantly engaged with the exploration and development of new compounds and NICHE molecules with complex chemistries. Key focus areas include: (a) develop and synthesize compounds of global standards involving Innovative and non-infringing processes (b) create core competency in few therapeutic segments involving complex chemistry. The division has developed strong skills in identification of non-infringing routes backed with IPR [Intellectual Property Rights] cell and is supported by a well-equipped analytical department, thereby creating an ‘IP capital’ for the company.
This unit has been envisaged to provide a competitive advantage for our international business efforts by providing strategic APIs involving the economic process.
The API Unit will allow Micro Labs to stretch its wings and create a bigger impact in the global pharmaceutical arena.